Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Doretha Clemons, Ph.D., MBA, PMP, has been a corporate IT executive and professor for 34 ...

Regardless of the outcome of the current health reform debate, patients are likely to continue to be asked to take more responsibility for their health care, whether through high-deductible health ...

There are shortcomings in the ways we have approached value assessment to date, writes the executive director of the Innovation and Value Initiative. Jennifer Bright is the executive director of the ...

Much of the biopharmaceutical industry this week is focused on the J.P. Morgan Healthcare Conference (JPM), where business leaders are investing in science and technologies with the potential to ...

Laying a clear path for incorporating reliable evidence on heterogeneity in value assessments could improve their applicability for healthcare decision making. The ICER perspective on what value means ...

Drug value assessments generally fail to account for the complexities of health care systems and thus can misinform price negotiations and lead to overly restrictive access policies. Studies have ...

When it comes to determining value, the U.S. health care system faces unique challenges. Without a better approach, the twin goals of continued innovation and broad-based drug affordability will be ...

Trying to gauge the value of new drugs and devices is becoming increasingly important in the U.S. health care system, something that other countries have done explicitly for years. Pressure to get ...

Typically a catalog has dollars invested in inventory, equipment, furnishings, buildings, and certainly labor. But a cataloger’s most-prized asset in the eyes of the investment community is its house ...

Tax certiorari lawyers often begin their presentation to the assessor with some version of the phrase, “all that glitters is not gold.” This reflects what most owners know: the economic reality is ...